GGrantIndex
Sort

40,608 grants matching prostate cancer

Multiparametric MRI-guided Prostate HDR Brachytherapy with Focal Tumor Boost

$356,850
Xiaofeng Yang · Emory University · R01 · FY2020 · CA

Multiparametric MRI-guided Prostate HDR Brachytherapy with Focal Tumor Boost

$356,850
Xiaofeng Yang · Emory University · R01 · FY2021 · CA

Hemostatic Factors Drive Prostate Cancer Pathogenesis

$356,850
Joseph S Palumbo · Cincinnati Childrens Hosp Med Ctr · R01 · FY2017 · CA

Hemostatic Factors Drive Prostate Cancer Pathogenesis

$356,850
Joseph S Palumbo · Cincinnati Childrens Hosp Med Ctr · R01 · FY2016 · CA

Dissecting and targeting a novel vulnerability in aggressive Rb1 and p53 doubly deficient prostate cancer

$356,850
Wenliang Li · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · CA

Multiparametric MRI-guided Prostate HDR Brachytherapy with Focal Tumor Boost

$356,850
Xiaofeng Yang · Emory University · R01 · FY2022 · CA

Defining the Biological Arc of Grade Group 1 Prostate Cancer

$356,850
Simpa Samuel Salami · University Of Michigan At Ann Arbor · R37 · FY2023 · CA

GSTP1-induced S-glutathionylation in lung cancer

$356,850
Adrianus (jos)l.j. Van Der Velden · University Of Vermont & St Agric College · R01 · FY2020 · CA

GSTP1-induced S-glutathionylation in lung cancer

$356,850
Adrianus (jos)l.j. Van Der Velden · University Of Vermont & St Agric College · R01 · FY2021 · CA

Designing a transcriptome-based, targeted theranostic platform for prostate cancer

$356,850
Renata Pasqualini · Rbhs -Cancer Institute Of New Jersey · R01 · FY2020 · CA

Hemostatic Factors Drive Prostate Cancer Pathogenesis

$356,850
Joseph S Palumbo · Cincinnati Childrens Hosp Med Ctr · R01 · FY2018 · CA

Hemostatic Factors Drive Prostate Cancer Pathogenesis

$356,850
Joseph S Palumbo · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · CA

Multiparametric MRI-guided Prostate HDR Brachytherapy with Focal Tumor Boost

$356,850
Xiaofeng Yang · Emory University · R01 · FY2018 · CA

Integrin-mediated mechanisms of prostate cancer progression

$356,850
Lucia R Languino · Thomas Jefferson University · R01 · FY2021 · CA

The JAZF1 Gene and Type 2 Diabetes

$356,828
Jeffrey Sklar · Yale University · R01 · FY2009 · DK

Effects of extracellular vesicles on miRNA activity in the skin

$356,819
My Georgia Mahoney · Thomas Jefferson University · R01 · FY2018 · AR

Intervention for Colorectal Cancer

$356,819
Northwestern University · R01 · FY2003 · CA

Roles of SRC-3 in Development and Disease

$356,771
Jianming Xu · Baylor College Of Medicine · R01 · FY2010 · DK

Core - Biomarker Development Laboratory (BDL)

$356,762
James G. Herman · University Of Pittsburgh At Pittsburgh · U2C · FY2022 · CA

CYCLIN D1 FUNCTION IN PROSTATE CANCER

$356,758
Georgetown University · R01 · FY2004 · CA

First Human Trial of Src/Abl-Targeted PET Tumor Imaging with F-18 SKI-249380

$356,747
Mark P. Dunphy · Sloan-Kettering Inst Can Research · R21 · FY2013 · CA

Imaging T-cell Activation and Co-stimulation in Prostate Cancer Immunotherapy

$356,747
Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2013 · CA

Endocrine disruptors: AR regulation and prostate cancer

$356,671
Karen E Knudsen · Thomas Jefferson University · R01 · FY2007 · ES

AR gene rearrangements and AR signaling in prostate cancer

$356,629
Scott M. Dehm · University Of Minnesota · R01 · FY2022 · CA

Role of BMP and FGF signaling during limb development

$356,620
Mark B Lewandoski · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA